Mucin 1 Gene (MUC1) and Gastric-Cancer Susceptibility

被引:25
|
作者
Saeki, Norihisa [1 ]
Sakamoto, Hiromi [1 ]
Yoshida, Teruhiko [1 ]
机构
[1] Natl Canc Ctr, Div Genet, Chuo Ku, Tokyo 1040045, Japan
来源
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2014年 / 15卷 / 05期
基金
日本学术振兴会;
关键词
gastric cancer; mucin; 1; Helicobacter pylori; genome-wide association study; single nucleotide polymorphism; cancer susceptibility gene; GENOME-WIDE ASSOCIATION; STEM-CELL ANTIGEN; HELICOBACTER-PYLORI INFECTION; JAPANESE POPULATION; STOMACH-CANCER; IDENTIFIES; PROGNOSTIC-SIGNIFICANCE; KOREAN POPULATION; EPITHELIAL-CELLS; E-CADHERIN;
D O I
10.3390/ijms15057958
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gastric cancer (GC) is one of the major malignant diseases worldwide, especially in Asia. It is classified into intestinal and diffuse types. While the intestinal-type GC (IGC) is almost certainly caused by Helicobacter pylori (HP) infection, its role in the diffuse-type GC (DGC) appears limited. Recently, genome-wide association studies (GWAS) on Japanese and Chinese populations identified chromosome 1q22 as a GC susceptibility locus which harbors mucin 1 gene (MUC1) encoding a cell membrane-bound mucin protein. MUC1 has been known as an oncogene with an anti-apoptotic function in cancer cells; however, in normal gastric mucosa, it is anticipated that the mucin 1 protein has a role in protecting gastric epithelial cells from a variety of external insults which cause inflammation and carcinogenesis. HP infection is the most definite insult leading to GC, and a protective function of mucin 1 protein has been suggested by studies on Muc1 knocked-out mice.
引用
收藏
页码:7958 / 7973
页数:16
相关论文
共 50 条
  • [31] Case-control Study of Single Nucleotide Polymorphisms of PSCA and MUC1 Genes with Gastric Cancer in a Chinese
    Li, Fang
    Zhong, Mei-Zuo
    Li, Jian-Huang
    Liu, Wei
    Li, Bin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (06) : 2593 - 2596
  • [32] MUC1, MUC5AC, and MUC6 polymorphisms, Helicobacter pylori infection, and gastric cancer: a systematic review and meta-analysis
    Giraldi, Luca
    Michelazzo, Maria B.
    Arzani, Dario
    Persiani, Roberto
    Pastorino, Roberta
    Boccia, Stefania
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2018, 27 (04) : 323 - 330
  • [33] Are Lewis b and H Type 1 on Helicobacter pylori Involved in Binding of Bacteria to MUC1 Mucin?
    Radziejewska, Iwona
    Borzym-Kluczyk, Malgorzata
    Leszczynska, Katarzyna
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 22 (03): : 347 - 353
  • [34] Augmentation of Fas ligand-induced apoptosis by MUC1 mucin
    Chaturvedi, R
    Srivastava, RK
    Hisatsune, A
    Shankar, S
    Lillehoj, EP
    Kim, KC
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (05) : 1169 - 1176
  • [35] MUC1 mucin interacts with calcium-modulating cyclophilin ligand
    Guang, Wei
    Kim, K. Chul
    Lillehoj, Erik P.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (06) : 1354 - 1360
  • [36] N-glycosylation of the MUC1 mucin in epithelial cells and secretions
    Parry, Simon
    Hanisch, Franz Georg
    Leir, Shih-Hsing
    Sutton-Smith, Mark
    Morris, Howard R.
    Dell, Anne
    Harris, Ann
    GLYCOBIOLOGY, 2006, 16 (07) : 623 - 634
  • [37] MUC1 Mucin: A Putative Regulatory (Checkpoint) Molecule of T Cells
    Agrawal, Babita
    Gupta, Nancy
    Konowalchuk, Jeffrey D.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [38] Production and characterization of an anti-(MUC1 mucin) recombinant diabody
    Denton, G
    Brady, K
    Lo, BKC
    Murray, A
    Graves, CRL
    Hughes, ODM
    Tendler, SJB
    Laughton, CA
    Price, MR
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999, 48 (01) : 29 - 38
  • [39] Genetic regulation of MUC1 expression by Helicobacter pylori in gastric cancer cells
    Guang, Wei
    Czinn, Steven J.
    Blanchard, Thomas G.
    Kim, K. Chul
    Lillehoj, Erik P.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 445 (01) : 145 - 150
  • [40] Production and characterization of an anti-(MUC1 mucin) recombinant diabody
    Graeme Denton
    Kevin Brady
    Benny K. C. Lo
    Andrea Murray
    C. Rosamund
    L. Graves
    Owen D. M. Hughes
    Saul J. B. Tendler
    Charles A. Laughton
    Michael R. Price
    Cancer Immunology, Immunotherapy, 1999, 48 : 29 - 38